Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Dermapharm - Confirms Full-Year Guidance For 2025

Nov 13 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE:

9M EBITDA MARGIN 26.5%

9M REVENUE EUR 869.4 MILLION

9M EBITDA EUR 230.8 MILLION

9M ADJUSTED EBITDA EUR 236 MILLION

9M ADJUSTED EBITDA MARGIN 27.1%

CONFIRMS FULL-YEAR GUIDANCE FOR 2025

Source text: ID:nEQ1XpLkwa

Further company coverage: DMPG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Dermapharm Holding SE

See all news